Elite Pharmaceuticals, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Elite Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $4.04K.
- Elite Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $90.21K.
- Elite Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $150.00K.
- Elite Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2017-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2026 was $318.75K, a 1551.14% increase from fiscal 2025.
- Elite Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $19.30K.
- Elite Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $8.80K, a 62.95% decline from fiscal 2016.
- Elite Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $23.75K, a 8.65% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $4.04K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $318.75K 10-K · filed 2026-06-29 | |
| 2025-12-31 | $90.21K 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $150.00K 10-Q · filed 2026-02-17 | |
| 2025-03-31 | $19.30K 10-K · filed 2025-06-30 | |
| 2017-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-14 | $8.80K 10-K · filed 2018-06-14 |
| 2016-12-31 | $4.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | $8.80K derived: sum of 4 quarters · filed 2018-06-14 |
| 2016-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-09 | |
| 2016-06-30 | $4.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-14 | $23.75K 10-K · filed 2018-06-14 |
| 2015-03-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-14 | $26.00K 10-K · filed 2017-06-14 |
| 2014-12-31 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | |
| 2014-03-31 | $24.30K 10-K · filed 2016-06-15 |